# Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome

> **NCT07736196** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 300 (estimated)

## Conditions studied

- Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
- Dual Anti-platelet Therapy

## Interventions

- **DRUG:** Aspirin-Free Strategy
- **DRUG:** Dual Antiplatelet Therapy

## Key facts

- **NCT ID:** NCT07736196
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2029-07-30
- **Final completion:** 2030-06-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736196, "Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07736196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*